Khiron Life Sciences Corp. Opens the Market
TORONTO, June 11, 2018 /CNW/ - Alvaro Torres, CEO, Khiron Life Sciences Corp. (KHRN), joined Richard Rohan, VP, Global Sales, Capital Formation, TMX Group, to open the market. Khiron is a Canadian integrated medical cannabis company with its core operations in Colombia, and is fully licensed in Colombia for the cultivation, production, domestic distribution, and international export of medical cannabis. Khiron Life Sciences Corp. commenced trading on TSX Venture Exchange on May 24, 2018.
SOURCE TMX Group Limited
Share this article